This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Company Filing History:
1 out of 834,411 Years Active: 2010
Title: Urmas Arumäe: Innovator in Cell Death Modulation
Introduction
Urmas Arumäe is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of cell biology, particularly in understanding the mechanisms of cell death. His innovative work has implications for drug development and therapeutic interventions.
Latest Patents
Urmas Arumäe holds a patent for a method of screening cell death modulators. This invention provides methods and compositions for identifying agents that modulate cell death, indicated by the expression of caspase-2 and/or caspase-7 in GDNF family growth factor deprived neuronal or nonneuronal cells. The methods for identifying such agents find particular application in drug development. He has 1 patent to his name.
Career Highlights
Throughout his career, Urmas has focused on the intersection of cell biology and pharmacology. His research has contributed to a deeper understanding of how certain agents can influence cell survival and death, paving the way for new therapeutic strategies.
Collaborations
Urmas has collaborated with esteemed colleagues in his field, including Mart Saarma and Li-Ying Yu. These partnerships have enhanced the scope and impact of his research.
Conclusion
Urmas Arumäe's work in cell death modulation represents a significant advancement in biomedical research. His innovative methods hold promise for future drug development and therapeutic applications.